Genetic Alteration of Keap1 Confers Constitutive Nrf2 Activation and Resistance to Chemotherapy in Gallbladder Cancer
Tatsuhiro Shibata(National Cancer Research Institute), Setsuo Hirohashi
Cited by 471
Related Papers
Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma
|Hepatology|2013|554
Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma
|Cancer|2004|224
Mutant IDH1 Confers an in Vivo Growth in a Melanoma Cell Line with BRAF Mutation
|American Journal Of Pathology|2011|130
Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma
|British Journal of Cancer|2011|127
Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma
|British Journal of Cancer|2009|95